Amoxicillin and Ceftriaxone: A Synergistic Association Against

Overview

Journal Open Forum Infect Dis

Specialty Infectious Diseases

Date 2024 Jun 5

PMID 38835495

Authors

Thibault Sixt

Florian Moretto

Sylvia Das Neves

Lucie Amoureux

Catherine Neuwirth

Lionel Piroth

Mathieu Blot

Pascal Chavanet

Julien Bador

Affiliations

Soon will be listed here.

Abstract

Among 15 strains of tested, a synergy between amoxicillin and ceftriaxone was observed in 14 (93%) according to minimal inhibitory concentration strips and 12 (80%) per the checkerboard methods, as well as for 2 of the 3 strains tested by the time-killing curve. This association may be an alternative treatment for listeriosis in the future.

Citing Articles

BANNMDA: a computational model for predicting potential microbe-drug associations based on bilinear attention networks and nuclear norm minimization.

Liang M, Liu X, Li J, Chen Q, Zeng B, Wang Z Front Microbiol. 2025; 15:1497886.

PMID: 39911712 PMC: 11794793. DOI: 10.3389/fmicb.2024.1497886.

References

Hof H . Listeriosis: therapeutic options. FEMS Immunol Med Microbiol. 2003; 35(3):203-5. DOI: 10.1016/S0928-8244(02)00466-2. View

Vicente M, Baquero F, Angel de Pedro M, Berenguer J . Penicillin-binding protein 3 of Listeria monocytogenes as the primary lethal target for beta-lactams. Antimicrob Agents Chemother. 1990; 34(4):539-42. PMC: 171640. DOI: 10.1128/AAC.34.4.539. View

Craft J, Feldman W, Nelson J . Clinicopharmacological evaluation of amoxicillin and probenecid against bacterial meningitis. Antimicrob Agents Chemother. 1979; 16(3):346-52. PMC: 352859. DOI: 10.1128/AAC.16.3.346. View

Wind C, de Vries H, van Dam A . Determination of in vitro synergy for dual antimicrobial therapy against resistant Neisseria gonorrhoeae using Etest and agar dilution. Int J Antimicrob Agents. 2014; 45(3):305-8. DOI: 10.1016/j.ijantimicag.2014.10.020. View

Mainardi J, Gutmann L, Acar J, Goldstein F . Synergistic effect of amoxicillin and cefotaxime against Enterococcus faecalis. Antimicrob Agents Chemother. 1995; 39(9):1984-7. PMC: 162868. DOI: 10.1128/AAC.39.9.1984. View

Petersen P, Labthavikul P, Jones C, Bradford P . In vitro antibacterial activities of tigecycline in combination with other antimicrobial agents determined by chequerboard and time-kill kinetic analysis. J Antimicrob Chemother. 2006; 57(3):573-6. DOI: 10.1093/jac/dki477. View

Delgado V, Ajmone Marsan N, de Waha S, Bonaros N, Brida M, Burri H . 2023 ESC Guidelines for the management of endocarditis. Eur Heart J. 2023; 44(39):3948-4042. DOI: 10.1093/eurheartj/ehad193. View

White R, Burgess D, Manduru M, Bosso J . Comparison of three different in vitro methods of detecting synergy: time-kill, checkerboard, and E test. Antimicrob Agents Chemother. 1996; 40(8):1914-8. PMC: 163439. DOI: 10.1128/AAC.40.8.1914. View

Baddour L, Wilson W, Bayer A, Fowler Jr V, Tleyjeh I, Rybak M . Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association. Circulation. 2015; 132(15):1435-86. DOI: 10.1161/CIR.0000000000000296. View

10.

Lepe J, Rodriguez-Villodres A, Martin-Gutierrez G, Luque R, Aznar J . In vitro study of synergy of ampicillin with ceftriaxone against Listeria monocytogenes. Rev Esp Quimioter. 2019; 32(5):465-468. PMC: 6790883. View

11.

Nau R, Prange H, Muth P, MAHR G, Menck S, Kolenda H . Passage of cefotaxime and ceftriaxone into cerebrospinal fluid of patients with uninflamed meninges. Antimicrob Agents Chemother. 1993; 37(7):1518-24. PMC: 188005. DOI: 10.1128/AAC.37.7.1518. View

12.

Heger W, Dierich M, Allerberger F . In vitro susceptibility of Listeria monocytogenes: comparison of the E test with the agar dilution test. Chemotherapy. 1997; 43(5):303-10. DOI: 10.1159/000239582. View

13.

Sueke H, Kaye S, Neal T, Hall A, Tuft S, Parry C . An in vitro investigation of synergy or antagonism between antimicrobial combinations against isolates from bacterial keratitis. Invest Ophthalmol Vis Sci. 2010; 51(8):4151-5. DOI: 10.1167/iovs.09-4839. View

14.

Orhan G, Bayram A, Zer Y, Balci I . Synergy tests by E test and checkerboard methods of antimicrobial combinations against Brucella melitensis. J Clin Microbiol. 2005; 43(1):140-3. PMC: 540140. DOI: 10.1128/JCM.43.1.140-143.2005. View

15.

Sopirala M, Mangino J, Gebreyes W, Biller B, Bannerman T, Balada-Llasat J . Synergy testing by Etest, microdilution checkerboard, and time-kill methods for pan-drug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother. 2010; 54(11):4678-83. PMC: 2976112. DOI: 10.1128/AAC.00497-10. View

16.

Kumaraswamy M, Do C, Sakoulas G, Nonejuie P, Tseng G, King H . Listeria monocytogenes endocarditis: case report, review of the literature, and laboratory evaluation of potential novel antibiotic synergies. Int J Antimicrob Agents. 2018; 51(3):468-478. PMC: 5860678. DOI: 10.1016/j.ijantimicag.2017.12.032. View

17.

Huang H, Jin W, Huang M, Ji H, Capen D, Xia Y . Gentamicin-Induced Acute Kidney Injury in an Animal Model Involves Programmed Necrosis of the Collecting Duct. J Am Soc Nephrol. 2020; 31(9):2097-2115. PMC: 7461673. DOI: 10.1681/ASN.2019020204. View

18.

Scheld W, Fletcher D, Fink F, Sande M . Response to therapy in an experimental rabbit model of meningitis due to Listeria monocytogenes. J Infect Dis. 1979; 140(3):287-94. DOI: 10.1093/infdis/140.3.287. View

19.

Amaya-Villar R, Garcia-Cabrera E, Sulleiro-Igual E, Fernandez-Viladrich P, Fontanals-Aymerich D, Catalan-Alonso P . Three-year multicenter surveillance of community-acquired Listeria monocytogenes meningitis in adults. BMC Infect Dis. 2010; 10:324. PMC: 2995464. DOI: 10.1186/1471-2334-10-324. View

20.

Hof H, Nichterlein T, Kretschmar M . Management of listeriosis. Clin Microbiol Rev. 1997; 10(2):345-57. PMC: 172923. DOI: 10.1128/CMR.10.2.345. View